Stay updated on JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial
Sign up to get notified when there's something new on the JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial page.

Latest updates to the JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial page
- CheckyesterdayChange DetectedThe record history now includes Revision: v3.5.0 and removes Revision: v3.4.3, updating the version history of the study record.SummaryDifference0.1%

- Check8 days agoChange DetectedA new revision entry v3.4.3 was added and the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedNew revision entry 'Revision: v3.4.2' was added to the study record history. The page also removes the notice about government funding and operating status.SummaryDifference0.9%

- Check44 days agoChange DetectedA new site-wide Notice about a lapse in government funding appears, informing that the NIH Clinical Center is open and directing to opm.gov for status, along with a new page revision label v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check51 days agoChange DetectedThe page now includes a glossary toggle and color-coded change indicators (green for additions and red for deletions) with explanatory text, and the new 'Revision: v3.4.0' label; the 'No FEAR Act Data' addition and the 'Revision: v3.3.4' deletion are reflected in the update.SummaryDifference1%

- Check65 days agoChange DetectedThe Record History now shows a new revision entry (v3.3.4) and excludes the previous v3.3.3 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial page.